The US Food and Drug Administration approved a novel tool Tuesday that uses genetic testing to help assess whether certain people are at risk of developing opioid use disorder. The AutoGenomics AvertD ...
Experts blamed persistently long waits for practical tests while the DVSA blamed better detection.
Oct 3 (Reuters) - The World Health Organization authorized Abbott Laboratories' (ABT.N), opens new tab mpox diagnostic test for emergency use on Thursday, the first such approval in the agency's ...
Both ethanol and THC have been shown to impair driving. But ethanol has a far shorter half-life than THC, making a determination of when a person became intoxicated by THC far less clear. A new study ...
The Food and Drug Administration (FDA) has cleared ACON Laboratories’ Flowflex COVID-19 Antigen Home Test, the first over-the-counter (OTC) antigen test. Previously, the test was authorized for ...
Two of the nation’s premier universities - Columbia University and the College of William & Mary - have recently decided to extend their test-optional admissions policies indefinitely. Their ...
The first-ever DNA test to help determine if someone has a greater risk of developing opioid use disorder was approved by the Food and Drug Administration (FDA) this week. The FDA approved the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results